PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY. Вопр. онкол. 2020, 66 (2), 135-142. https://doi.org/10.37469/0507-3758-2020-66-2-135-142.